Element Biosciences

Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. We are developing a modular and high-performing DNA sequencing platform that will deliver high quality data, workflow flexibility, and make next-generation sequencing technology more accessible. Our proprietary approach to improve the signal-to-noise ratio allows us to provide groundbreaking innovations in surface chemistry, instrumentation and biochemistry to drastically decrease the run cost and capital cost while delivering high sequencing data quality.

Element Biosciences headquartered in United States, North America, operates in the Biotechnology, Life Science, Genetics, Health Diagnostics sector. The company focuses on Biotechnology and has secured $54.2B in funding across 80 round(s). With a team of 251-500 employees, Element Biosciences is actively contributing to advancements in Biotechnology. Their latest funding round, Series D - Element Biosciences, raised $277.0M. Discover more about their projects, partnerships, and impact on our platform.